Takashi Nakahara Selected Research

sofosbuvir drug combination ledipasvir

4/2018	Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study.
11/2017	Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Nakahara Research Topics

Disease

60	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2012
24	Fibrosis (Cirrhosis) 03/2024 - 07/2013
21	Neoplasms (Cancer) 11/2023 - 08/2012
18	Infections 01/2023 - 11/2013
16	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 06/2015
16	Chronic Hepatitis C 01/2021 - 12/2014
11	Non-alcoholic Fatty Liver Disease 01/2023 - 02/2014
8	Liver Diseases (Liver Disease) 01/2023 - 02/2014
7	Hepatic Encephalopathy 09/2023 - 07/2013
7	Chronic Hepatitis B 01/2021 - 01/2016
6	Neoplasm Metastasis (Metastasis) 11/2023 - 10/2018
6	Inflammation (Inflammations) 01/2023 - 04/2010
5	Hepatitis B 01/2023 - 03/2017
5	Thrombosis (Thrombus) 04/2021 - 06/2015
5	Disease Progression 04/2020 - 04/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2018
3	Sarcopenia 02/2020 - 10/2018
3	Dyslipidemias (Dyslipidemia) 08/2019 - 11/2012
3	Hemorrhage 01/2018 - 11/2015
2	Portal Hypertension 03/2024 - 11/2020
2	Hypertension (High Blood Pressure) 11/2023 - 08/2019
2	Proteinuria 11/2023 - 08/2023
2	Acute-On-Chronic Liver Failure 10/2023 - 10/2023
2	Acute Liver Failure (Fulminant Hepatic Failure) 09/2023 - 12/2017
2	Post-Cardiac Arrest Syndrome 01/2023 - 01/2015
2	Insulin Resistance 03/2022 - 02/2014
2	Alcoholic Fatty Liver 07/2021 - 11/2012
2	Hepatitis 01/2021 - 12/2018
2	Wounds and Injuries (Trauma) 01/2021 - 11/2015
2	Necrosis 01/2021 - 01/2018
2	Microsatellite Instability 10/2020 - 07/2020
2	Hepatitis C 09/2020 - 12/2014
2	Edema (Dropsy) 02/2020 - 08/2016
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 12/2018
2	Lymphatic Metastasis 08/2019 - 08/2012

Drug/Important Bio-Agent (IBA)

21	lenvatinibIBA 11/2023 - 01/2019
13	Antiviral Agents (Antivirals)IBA 01/2023 - 08/2016
13	InterferonsIBA 11/2020 - 07/2013
12	Bevacizumab (Avastin)FDA Link 03/2024 - 08/2021
12	atezolizumabIBA 03/2024 - 08/2021
12	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2012
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2018
8	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 12/2014
6	CytokinesIBA 09/2023 - 01/2009
6	Proteins (Proteins, Gene)FDA Link 08/2023 - 12/2009
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2014
6	Hemoglobins (Hemoglobin)IBA 01/2023 - 05/2009
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 12/2017
6	AntigensIBA 01/2021 - 11/2016
6	asunaprevirIBA 01/2020 - 08/2016
6	daclatasvirIBA 01/2020 - 08/2016
5	Alanine Transaminase (SGPT)IBA 01/2023 - 03/2014
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 03/2017
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2014
5	SofosbuvirIBA 11/2020 - 06/2017
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2024 - 05/2016
4	NucleotidesIBA 01/2023 - 01/2018
4	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2017
4	regorafenibIBA 01/2021 - 09/2018
3	nasIBA 03/2024 - 06/2020
3	Interleukin-6 (Interleukin 6)IBA 10/2023 - 12/2009
3	Interleukin-8 (Interleukin 8)IBA 09/2023 - 12/2009
3	Prothrombin (Factor II)IBA 09/2023 - 12/2017
3	BilirubinIBA 08/2023 - 12/2017
3	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 08/2012
3	EnzymesIBA 02/2021 - 10/2019
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 11/2016
3	Fetal Proteins (Fetoprotein)IBA 11/2020 - 01/2012
3	NucleosidesIBA 01/2019 - 01/2018
3	HMGB1 Protein (HMG1)IBA 01/2018 - 12/2009
2	Alkaline PhosphataseIBA 03/2024 - 10/2019
2	CreatinineIBA 08/2023 - 08/2016
2	AlbuminsIBA 08/2023 - 10/2019
2	Therapeutic UsesIBA 01/2023 - 07/2021
2	LipidsIBA 01/2023 - 11/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 11/2012
2	Carrier Proteins (Binding Protein)IBA 01/2022 - 09/2020
2	Immune Checkpoint InhibitorsIBA 02/2021 - 10/2020
2	glecaprevir and pibrentasvirIBA 01/2021 - 01/2020
2	pembrolizumabIBA 10/2020 - 07/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2020 - 01/2009
2	pibrentasvirIBA 04/2020 - 03/2019
2	glecaprevirIBA 04/2020 - 03/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2018
2	AmmoniaIBA 08/2019 - 01/2019
2	ChemokinesIBA 07/2019 - 01/2018
2	ledipasvirIBA 12/2018 - 11/2017
2	entecavir FDA Link 12/2018 - 01/2018

Therapy/Procedure

52	Therapeutics 03/2024 - 11/2010
12	Drug Therapy (Chemotherapy) 06/2022 - 08/2012
8	Radiotherapy 01/2023 - 08/2012
5	Liver Transplantation 09/2023 - 03/2017
3	Hepatectomy 01/2022 - 08/2012
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2019 - 07/2013
3	Resuscitation 10/2016 - 01/2015
2	Aftercare (After-Treatment) 10/2023 - 01/2023
2	Cardiopulmonary Resuscitation (CPR) 01/2023 - 11/2015
2	Induced Hypothermia 01/2023 - 01/2015
2	Bariatric Surgery 01/2022 - 07/2021